Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson’s Disease-Reference-Cited by-同舟云学术

Advances in the Research of Risk Factors and Prodromal Biomarkers of Parkinson’s Disease

Published:2018-12-27 Issue:2 Volume:10 Page:973-990
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Xie Fen¹,Gao Xiaoya¹,Yang Wanlin¹,Chang Zihan¹,Yang Xiaohua¹,Wei Xiaobo¹,Huang Zifeng¹,Xie Huifang¹,Yue Zhenyu²,Zhou Fengli³,Wang Qing¹^ORCID

Affiliation:

1. Department of Neurology, Zhujiang Hospital of Southern Medical University, Gongye Road 253, Guangzhou, Guangdong 510280, P. R. China

2. Department of Neurology, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Avenue, Hess Research Center Ninth Floor, New York, New York 10029, United States

3. Department of Respiratory Medicine, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, P. R. China

Funder

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Guangzhou City

Guangdong Province

Leading Talent in Talents Project Guangdong High-level Personnel of Special Support Program

Scientific Research Foundation of Guangzhou

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00520

Reference280 articles.

1. Toward a redefinition of Parkinson's disease

2. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease

3. PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results

4. PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease

5. MDS research criteria for prodromal Parkinson's disease

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmaceutical Considerations of Translabial Formulations for Treatment of Parkinson’s Disease: A Concept of Drug Delivery for Unconscious Patients;Current Drug Delivery;2023-10

2. Glymphatic Magnetic Resonance Imaging: Part II—Applications in Sleep and Neurodegenerative Diseases;Investigative Magnetic Resonance Imaging;2023

3. How Well Do Rodent Models of Parkinson’s Disease Recapitulate Early Non-Motor Phenotypes? A Systematic Review;Biomedicines;2022-11-24

4. The use of neurotoxins in fundamental, medical and biological sciences on the example of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine;Toxicological Review;2022-10-30

5. Aquaporin-4 Polymorphisms Are Associated With Cognitive Performance in Parkinson’s Disease;Frontiers in Aging Neuroscience;2022-03-09